Arief Pramuhanto - Indofarma Tbk Pres Director
| INAF Stock | IDR 126.00 0.00 0.00% |
Insider
Arief Pramuhanto is Pres Director of Indofarma Tbk
| Age | 61 |
| Phone | 62 21 8832 3971 |
| Web | https://indofarma.id |
Indofarma Tbk Management Efficiency
The company has return on total asset (ROA) of (0.0451) % which means that it has lost $0.0451 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5895) %, meaning that it generated substantial loss on money invested by shareholders. Indofarma Tbk's management efficiency ratios could be used to measure how well Indofarma Tbk manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Engineer Sophiaan | Lion Metal Works | 77 | |
| Richard Purwadi | Diamond Food Indonesia | 47 | |
| Tsen Chen | Diamond Food Indonesia | 69 | |
| Budi SE | Garuda Metalindo Tbk | 45 | |
| Henry MM | Metro Healthcare Indonesia | 65 | |
| I Candrajaya | Garuda Metalindo Tbk | N/A | |
| Remanja Intansuri | Diamond Food Indonesia | 37 | |
| Martua Sihaloho | Cisarua Mountain Dairy | 41 | |
| Edhi Sebayang | Capital Financial Indonesia | 39 | |
| Khairilman MM | Lion Metal Works | 47 | |
| Bambang Sutantio | Cisarua Mountain Dairy | 64 | |
| Bharat Joshi | Cisarua Mountain Dairy | 39 | |
| H Sophiaan | Lion Metal Works | 71 | |
| Ruliff Susanto | Sentra Food Indonesia | 46 | |
| Engineer Msc | Capital Financial Indonesia | 57 | |
| Evelina | Metro Healthcare Indonesia | N/A | |
| Arjoso Wisanto | Cisarua Mountain Dairy | 62 | |
| Edy Jonathan | Capital Financial Indonesia | 55 | |
| Agustus Nugroho | Sentra Food Indonesia | 59 | |
| Axel Sutantio | Cisarua Mountain Dairy | 34 | |
| Dedi A | Metro Healthcare Indonesia | N/A | |
Management Performance
| Return On Equity | -0.59 | |||
| Return On Asset | -0.0451 |
Indofarma Tbk Leadership Team
Elected by the shareholders, the Indofarma Tbk's board of directors comprises two types of representatives: Indofarma Tbk inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Indofarma. The board's role is to monitor Indofarma Tbk's management team and ensure that shareholders' interests are well served. Indofarma Tbk's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Indofarma Tbk's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hilda Yani, Co Sec | ||
| Fudoli Rustam, Marketing Mang | ||
| Jejen Nugaha, Production Director | ||
| Kamelia Faisal, Director Director | ||
| Arief Pramuhanto, Pres Director | ||
| Weny Maulatsih, S Commissioners | ||
| SE CA, Head Unit |
Indofarma Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Indofarma Tbk a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.59 | |||
| Return On Asset | -0.0451 | |||
| Profit Margin | (0.1) % | |||
| Operating Margin | (0.06) % | |||
| Current Valuation | 3.17 T | |||
| Shares Outstanding | 3.1 B | |||
| Shares Owned By Insiders | 88.00 % | |||
| Price To Book | 8.91 X | |||
| Price To Sales | 1.25 X | |||
| Revenue | 2.9 T |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Indofarma Stock
Indofarma Tbk financial ratios help investors to determine whether Indofarma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Indofarma with respect to the benefits of owning Indofarma Tbk security.